AstraZeneca Plots Crucial IDO Phase III Combo Trial With Incyte Post author:Sam Post published:October 30, 2017 Post category:BioPharma Astra and Incyte are pushing forward on the development of immunotherapy combination treatments. Source: BioSpace You Might Also Like Providence Medical Technology Expands Offering Of Posterior Cervical Fusion Solutions September 26, 2017 This Bay Area Biotech Snags $293 Million Pain Drug Pact With Novartis AG May 7, 2017 Ligand Reports First Quarter 2017 Financial Results May 9, 2017
Providence Medical Technology Expands Offering Of Posterior Cervical Fusion Solutions September 26, 2017